What DEKA Research & Development does

DEKA Research & Development Corp. is a privately held, founder-led medical technology development company founded in 1982 by inventor Dean Kamen and headquartered in Manchester, New Hampshire. The company employs nearly 1,000 engineers, technicians, machinists, and designers who develop life-changing medical devices, with a portfolio exceeding 6,000 patents. Its core technical competency is fluidics, which it applies across infusion systems, subcutaneous drug delivery pumps, and on-site medical-grade water production.

DEKA's product portfolio spans multiple medical domains: drug delivery (twiist Automated Insulin Delivery System, Remunity pump for Remodulin, microneedle applicators, SAFEflow infusion controller), home dialysis systems (Amia, Kaguya, HemoCare), mobility solutions (iBOT 3000 and iBOT PMD stair-climbing wheelchairs, LUKE robotic arm), water purification (Slingshot), and autonomous robotics (SENTRY). The company has also spun off notable inventions into separate ventures, including the Segway and the Coke Freestyle beverage dispenser.

DEKA's business model combines three revenue streams: licensing of proprietary technology to established healthcare and pharmaceutical partners, contract R&D services for partners such as Baxter and ARMI, and direct manufacturing of select devices. Distribution is achieved primarily through OEM/embedded partnerships rather than direct sales — most notably with Baxter/Vantive for dialysis, Mobius Mobility and 2Kerr for the iBOT, and pharmaceutical partners for insulin and Remodulin delivery systems. Founder Dean Kamen retains full ownership and operational control of the company, which has remained private since founding.

Name

DEKA Research & Development

Legal name

DEKA Research & Development Corp.

Website

https://dekaresearch.com

Company type

Private

Founded year

1982

Operating status

Operating

Headcount range

501–1,000 employees

Short description

DEKA Research & Development is a privately held, founder-led medical technology developer founded in 1982 by Dean Kamen. With nearly 1,000 employees and 6,000+ patents, it designs and licenses devices in drug delivery, dialysis, mobility, and autonomous robotics to major healthcare partners.

Ownership category

akta.pro rank

Product category

Medical Device Development and Manufacturing

NAICS

Surgical and Medical Instrument Manufacturing (339112), Research and Development in the Physical, Engineering, and Life Sciences (54171)

SIC

Surgical & Medical Instruments & Apparatus (3841), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)

akta.pro primary industry

Personal Medical Devices & Home Diagnostics (Thermometers, Blood Pressure Monitors, Glucose Meters, Rapid Tests) (CRADAMAK)

Keywords

• Medical device development
• Drug delivery systems
• Mobility assistance technology
• Water purification equipment
• Autonomous robotics platforms

Headquarters

HQ city

Manchester

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Operations, Infrastructure, Supply Chain, Marketing or Sales

Revenue model

1. Medical Device Development & Licensing: DEKA develops medical technologies and licenses them to established healthcare companies. Examples include the Remunity pump licensed to a partner company and the twiist Automated Insulin Delivery System.
2. Product Manufacturing & Sales: Manufacturing and selling medical devices developed in-house, such as infusion systems, dialysis systems, and mobility enhancement products.
3. Contract R&D Services: Research and development contracting services for healthcare innovation, including partnerships with organizations like Baxter and ARMI.

Go-to-market motion2 records

Distribution channels5 records

Marketing channels4 records

Core offering

DEKA Research & Development Corp. is a private engineering R&D company that conceives, designs, prototypes, and licenses medical device technologies spanning drug delivery, dialysis, infusion, mobility, prosthetics, water purification, and autonomous robotics. The firm typically commercializes through licensing, OEM partnerships, and exclusive distribution agreements with established manufacturers such as Baxter (Vantive), Mobius Mobility, and 2Kerr, rather than via direct consumer sales. Its portfolio is anchored by more than 6,000 patents and a near-1,000-person staff of engineers, technicians, machinists, and designers in Manchester, New Hampshire.

Product overview

DEKA Research & Development is a technology development company with over 6,000 patents that creates life-changing medical technologies. The company's product portfolio centers on healthcare innovation including: insulin delivery systems (twiist Automated Insulin Delivery System, Remunity Pump, Subcutaneous Drug Delivery System), dialysis systems (Baxter Amia, Kaguya, HemoCare), mobility solutions (iBOT stair-climbing wheelchairs, LUKE robotic arm), drug administration devices (microneedle applicators, Daisy device), infusion systems (SAFEflow controller), water purification (Slingshot), and autonomous robotics (SENTRY Robot). DEKA also developed notable inventions like the Segway and Coke Freestyle that were spun off as separate ventures. The company operates with a core competency in fluidics and leverages this expertise across multiple product lines from drug delivery to water treatment.

Differentiator

Problem solved

Functional benefit

Brands

• iBOT: iBOT 3000 was released in 2002 as the first stair-climbing wheelchair. The remastered iBOT PMD offers enhanced features and accessibility.
• Slingshot
• LUKE Arm
• Remunity
• twiist

Products and services

• twiist Automated Insulin Delivery System Automated insulin delivery system providing precise, continuous insulin dosing for diabetes management; licensed to pharmaceutical partners for commercial distribution.
• Remunity Pump Pump system for stable subcutaneous delivery of Remodulin to patients requiring pulmonary arterial hypertension treatment; licensed to a partner for distribution.
• iBOT Mobility System Stair-climbing wheelchair platform with balance and multi-terrain capabilities, originally released as iBOT 3000 in 2002 and remastered as iBOT PMD; distributed through Mobius Mobility and 2Kerr.
• LUKE Robotic Arm Advanced robotic prosthetic arm that restores upper-limb function and quality of life for individuals with limb loss.
• Subcutaneous Drug Delivery System Small, lightweight, wearable infusion pumps with enhanced delivery accuracy, occlusion detection, and monitoring compatibility for delivering drugs such as insulin and Remodulin.
• Therapeutic Self-Administration / Microneedle Applicator Microneedle applicator enabling self-administration of therapeutics with virtually no pain, featuring dose-sparing delivery and reduced waste versus conventional needles.
• Baxter Amia Dialysis System User-friendly at-home hemodialysis system developed with Baxter (now Vantive), delivering life-saving renal care to patients worldwide.
• Kaguya Dialysis System Next-generation at-home dialysis system developed in collaboration with Baxter (now Vantive) for renal therapy patients.
• HemoCare Home Hemodialysis Machine Home hemodialysis equipment providing patients with life-saving kidney treatment in a home setting.
• Medical Water / Drug Production System (Caspian) On-site medical-grade water production devices for injection using DEKA's fluidics expertise, featuring cloud-based monitoring for real-time data gathering and fleet health assessment.
• SENTRY Robot Autonomous robotics platform capable of exploring, patrolling, delivering, traveling various terrains, and tackling curbs; remotely monitored or autonomously operated.
• Slingshot Water Purification Machine Water purification system leveraging DEKA's Stirling engine technology to address water scarcity by producing clean drinking water.
• Stirling Engine Improved Stirling engine design from DEKA applicable for power generation and refrigeration cycles, also underpinning the Slingshot water purification platform.

Quantifiable outcome

• Established as market leader in renal therapies with Baxter partnership
• +1 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature9 records

Partnerships

Eight partnerships are on record, tiered core and minor.

• West Coast CustomscoreStrategic or Co-development Partner · 1 January 2026DEKA partnered with West Coast Customs and will.i.am to develop the TRINITY - an all-electric, self-balancing single-passenger 3-wheel micromobility vehicle. DEKA contributed technology expertise and the collaboration debuted at CES in January 2026.
• NVIDIAcoreTechnology or Integration · 1 January 2026NVIDIA provided DGX Spark technology for the TRINITY micromobility vehicle project developed with West Coast Customs and DEKA Research & Development.
• Diatech DiabetesminorStrategic or Co-development Partner · 1 October 2025DEKA Research & Development acquired assets from Diatech Diabetes in October 2025, expanding its presence in the diabetes technology market.
• Baxter International (Vantive)coreStrategic or Co-development PartnerDEKA partnered with Baxter on their first dialysis system, and DEKA's technologies have established themselves as the market leader in renal therapies. User-friendly at-home systems including the Amia and Kaguya deliver life-saving care worldwide. The renal care business is now part of Vantive.
• Mobius MobilitycoreChannel Partner/ Reseller/ DistributorMobius Mobility distributes the iBOT PMD (Personal Mobility Device), DEKA's remastered stair-climbing wheelchair with more features and better accessibility.
• 2KerrcoreChannel Partner/ Reseller/ Distributor2Kerr distributes the iBOT Duo, DEKA's autonomous mobility technology platform.
• ARMI (Advanced Regenerative Manufacturing Institute)coreStrategic or Co-development PartnerDEKA partnered with ARMI to advance the bioeconomy of the United States. Technologies focus on manufacturing of cells, tissues, and organs to usher in a new era of biofabrication.
• will.i.amminorStrategic or Co-development PartnerCollaborated with will.i.am on the TRINITY all-electric micromobility vehicle project that debuted at CES 2026.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Stryker: Stryker's broad medical device portfolio, including surgical instruments, orthopedic implants, and mobility solutions, overlaps with DEKA's surgical instrument development and LUKE Arm prosthetic initiatives as a broad incumbent competitor and potential acquirer.
• Baxter International (Vantive): Baxter's renal-care business (now Vantive) is both DEKA's primary dialysis distribution partner and a broad incumbent in the same home dialysis and infusion markets where DEKA's Amia, Kaguya, and HemoCare systems compete.
• Medtronic: Medtronic operates across the same drug-delivery, diabetes (MiniMed), and surgical instrument categories that DEKA serves, and competes head-to-head in automated insulin delivery while also being a potential partner for licensing DEKA IP.
• Edwards Lifesciences: Edwards is a leader in cardiac devices and structural heart products, comparable to DEKA's cardiac stent development; both target the cardiovascular device space with regulated, IP-driven products sold to hospitals and specialists.
• Abbott: Abbott's FreeStyle Libre CGM franchise and diabetes care business directly overlaps with DEKA's insulin delivery and monitoring offerings, and Abbott also operates broadly in medical devices and diagnostics where DEKA competes or partners.

Emerging players

• Ekso Bionics: Ekso Bionics develops robotic exoskeletons and powered mobility aids that overlap with DEKA's iBOT and SENTRY robotics platforms, targeting similar rehabilitation, mobility-impaired, and industrial end markets with partial technology overlap.

Direct peers

• Insulet: Insulet's Omnipod automated insulin delivery system competes directly with DEKA's twiist AID platform in the patch-pump diabetes market, serving the same patient and provider base with a similar wearable drug-delivery value proposition.
• Mobius Mobility: Mobius distributes DEKA's iBOT PMD stair-climbing wheelchair; it is also a peer in advanced powered mobility devices for complex rehabilitation, sharing the same end users and clinical buyer profile.
• Dexcom: Dexcom's continuous glucose monitors pair with and compete for interface integration with DEKA's twiist AID, making it a direct diabetes-ecosystem peer with overlapping patient, provider, and payer relationships.
• Tandem Diabetes Care: Tandem's t:slim X2 insulin pump is a direct competitor to DEKA's twiist system, both targeting Type 1 diabetes patients with automated insulin delivery integrated to CGMs and using a similar B2B2C commercial motion.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/people/DEKA-Research-and-Development/100063520032185
• LinkedInlinkedin.com/company/deka-research-&-development
• Instagraminstagram.com/dekaresearch

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about DEKA Research & Development